Table 2: The medical characteristics of the studied qatari patients with type 2 dm, primary health care centers, 2014. (N = 532).

Variable Frequency (%) GFRP score WHO/ISH Chart
χ2 P-value Χ2 P-value
Systolic Hypertension (mmHg) 114 (21.4) 140.1 <0.000* 107.2 <0.000*
Current Smoker 22 (4.1) 24.9 <0.000* 14.8 0.002*
Duration of Type 2 DM (years) - 28.3 0.005* 28.6 0.004*
˂5
5- ˂10
10- ˂15
15- ˂20
≥20
81 (15.2)
154 (28.9)
145 (27.3)
76 (14.3)
76 (14.3)
- - - -
Taking antihypertensive medication (n=387) 382 (98.7) 3.195 0.363 0.263 0.967
BMI (Kg/m2) - 13.0 0.043* 25.1 <0.000*
Normal
Overweight
Obese
32 (6)
133 (25)
367 (69)
- - - -
Glycemic Control (HbA1C (%) > 7.0%) 346 (65) 0.8 0.861 0.281 0.964
Serum Cholesterol (mmol/L) - 5.4 0.497 19.6 0.003*
Desirable
Borderline
High
436 (82.0)
76 (14.2)
20 (3.8)
- - - -